Find clinical trials for Kidney Disease in Toronto, ON
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Kidney Disease trials near Toronto, ON, CAN:
Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors ...
Phase 3
Toronto, Ontario, Canada and 17 other locations
baxdrostat in combination with dapagliflozin compared with baxdrostat/placebo on albuminuria, as well as safety, in participants with chronic kidney...
Phase 2
Etobicoke, Ontario, Canada and 70 other locations
tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...
Phase 2, Phase 3
Toronto, Canada and 330 other locations
with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Part...
Phase 3
Brampton, Canada and 560 other locations
This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific t ...
Phase 2
Toronto, Ontario, Canada and 156 other locations
This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medici...
Phase 3
Toronto, Ontario, Canada and 102 other locations
We are doing this study to learn more about how tirzepatide may help fight chronic kidney disease in people with obesity with or wi...
Phase 2
Toronto, Canada and 26 other locations
The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.
Phase 3
Oshawa, Ontario, Canada and 96 other locations
to healthy participants (Phase I) or participants with end-stage kidney disease receiving hemodialysis through a central venous cat...
Phase 1, Phase 2
Ridgewood, New York, United States and 40 other locations
and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney...
Phase 3
Toronto, Ontario, Canada and 739 other locations
Clinical trials
Research sites
Resources
Legal